A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
NCT ID: NCT01716936
Last Updated: 2013-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2012-07-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAGEC Implant
All patients implanted with the MAGEC System will be reviewed for inclusion into this retrospective study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cobb angle measurement of 30 degrees or greater at the time of primary surgery
* Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery
* Age less than 11 years old at the time of MAGEC implant
* Implanted with the MAGEC system as either a primary or secondary revision spinal bracing procedure
* Patient has been implanted for a minimum of 6 months
* Patient signs informed consent for the use of their personal private data
Exclusion Criteria
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ellipse Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Behrooz A Akbarnia, MD
Role: PRINCIPAL_INVESTIGATOR
San Diego Center for Spinal Disorders
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cairo Public Hospital
Cairo, , Egypt
University of Helsinki
Helsinki, , Finland
Turku University Hospital
Turku, , Finland
University of Hong Kong
Hong Kong, , Hong Kong
Instituto Rizzoli
Bologna, , Italy
Bambin Gesu
Rome, , Italy
Starship Children's Hospital
Auckland, , New Zealand
Ankara Gazi Universitesi Hastanesi
Ankara, , Turkey (Türkiye)
Hacettepe University Hospital
Ankara, , Turkey (Türkiye)
Florence Nightingale Hospital Ortopedi Bolumu
Istanbul, , Turkey (Türkiye)
Marmara Üniversitesi Eğt.ve Arş.Hastanesi
Istanbul, , Turkey (Türkiye)
Ege Sağlık Hastanesi
Izmir, , Turkey (Türkiye)
Royal National Orthopaedic Hospital NHS Trust
Stanmore, Middlesex, United Kingdom
University Hospital of Wales
Cardiff, , United Kingdom
The Harley Street Clinic
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR0056
Identifier Type: -
Identifier Source: org_study_id